Emanuele Gilardi, Fulvio Pomero, Enrico Ravera, Andrea Piccioni, Michele Cosimo Santoro, Nicola Bonadia, Annamaria Carnicelli, Luca Di Maurizio, Luca Sabia, Yaroslava Longhitano, Angela Saviano, Veronica Ojetti, Gabriele Savioli, Christian Zanza, Francesco Franceschi
Several studies have suggested the potential role of Magnesium Sulfate (MgSO4 ) for the treatment of Atrial Fibrillation (AF) but, in clinical practice, the use of magnesium is not standardized although it is largely used for the treatment of supraventricular arrhythmias. Objectives. We evaluated the role of MgSO4 infusion in association with flecainide in cardioversion of patients presenting in ED with symptomatic AF started less than 48 h before. We retrospectively searched for all patients presented in ED from 1 January 2019 to 31 December 2019 requiring pharmacological cardioversion with flecainide 2 mg/kg...
September 21, 2022: Journal of Clinical Medicine